🇺🇸 FDA
Patent

US 12318401

Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy

granted A61KA61K31/704A61K35/13

Quick answer

US patent 12318401 (Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy) held by The Regents of the University of California expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/704, A61K35/13, A61K38/00, A61K47/02